v3.19.3
Stockholders' Deficit (Tables)
9 Months Ended
Sep. 30, 2019
Series RX-1 Preferred Stock [Member]  
Schedule of preferred stock transactions

Series RX-1 Preferred Stock Debt Holder  Aggregate Principal and Interest Consideration Exchanged/Paid  Total Number of Series RX-1 Preferred Shares Issued  Total Number of Common Shares Into Which Shares are Convertible (Before Any Potential Adjustment)
Related party investor (also a shareholder)  $69,041    52,325    5,232,500 
Related party investor (also a shareholder)   458,729    324,262    32,426,200 
Company’s outside director (also a shareholder)   73,560    65,396    6,539,600 
Company’s outside director (also a shareholder)   36,583    32,367    3,236,700 
Company’s outside director (also a shareholder)   22,510    20,351    4,070,200 
Related party investor (also a shareholder)   22,580    20,483    2,048,300 
Company’s general counsel (also a shareholder)   37,251    33,873    3,387,300 
Related party investor (also a shareholder)   1,070,974    822,639    82,263,900 
Non-related party investor   34,952    26,568    2,656,800 
Combined Total  $1,826,180    1,418,615    141,861,500 

Series RX-2 Preferred Stock [Member]  
Schedule of preferred stock transactions

Series RX-2 Preferred Stock Warrant Debt Holder  Aggregate Principal and Interest Consideration Exchanged/Paid  Total Number of RX- 2 Shares For Which Warrants Issued Are Exercisable  Total Number of Common Shares Into Which Shares are Convertible (Before Any Potential Adjustment)
Related party employee (also a shareholder)  $29,003    58,006    5,800,600 
Company’s outside director (also a shareholder)   149,021    298,042    29,804,200 
Company’s outside director (also a shareholder)   51,924    103,848    10,384,800 
Related party consultant (also a shareholder)   87,009    174,018    17,401,800 
Related party consultant (also a shareholder)   81,651    163,302    16,330,200 
Related party consultant (also a shareholder)   92,050    184,100    18,410,000 
Combined Total  $490,658    981,316    98,131,600 

Series RX-3 Preferred Stock [Member]  
Schedule of preferred stock transactions

Series RX-3 Preferred Stock Warrant Debt Holder  Aggregate Principal and Interest Consideration Exchanged/Paid  Total Number of RX- 3 Shares For Which Warrants Issued Are Exercisable  Total Number of Common Shares Into Which Shares are Convertible (Before Any Potential Adjustment)
Company’s controller (also a shareholder)  $235,775    81,806    81,806,000 
Company’s president and chief executive officer (also a shareholder)   609,716    211,733    211,733,000 
Company’s general counsel (also a shareholder)   552,156    187,673    187,673,000 
Combined Total  $1,397,647    481,212    481,212,000